NCT05518747

Brief Summary

The present study is a double-blinded randomized clinical trial with a duration of 12 weeks.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 29, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

November 2, 2022

Status Verified

November 1, 2022

Enrollment Period

10 months

First QC Date

August 22, 2022

Last Update Submit

November 1, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in microbial composition in dental plaque

    Changes in alpha and beta diversity of microbial composition

    Baseline vs. week 6 and week 12

Secondary Outcomes (5)

  • Changes in dental plaque

    Baseline vs. week 6 and week 12

  • Changes in bleeding on probing

    Baseline vs. week 6 and week 12

  • Changes in probing pocket depth

    Baseline vs. week 6 and week 12

  • Changes in clinical attachment level

    Baseline vs. week 6 and week 12

  • Changes in salivary levels of inflammatory cytokines

    Baseline vs. week 6 and week 12

Study Arms (2)

Probiotic

EXPERIMENTAL

In this group participants will receive non-surgical periodontal treatment at baseline, which will for 12 weeks

Dietary Supplement: Probiotic

Placebo

PLACEBO COMPARATOR

In this group participants will receive non-surgical periodontal treatment at baseline, which will for 12 weeks

Dietary Supplement: Placebo

Interventions

ProbioticDIETARY_SUPPLEMENT

In this group participants will receive probiotic supplements twice a day (morning and evening) for a period of 12 weeks.

Probiotic
PlaceboDIETARY_SUPPLEMENT

In this group participants will receive placebo twice a day (morning and evening) for at period of 12 weeks.

Placebo

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Periodontitis stage 2-3, Grade B-C, generalized

You may not qualify if:

  • Use of systemic antibiotics within the latest three months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Copenhagen, Department of Odontology

Copenhagen, 2200, Denmark

RECRUITING

MeSH Terms

Conditions

Periodontitis

Interventions

Probiotics

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dietary SupplementsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Computerized randomization only known to the principal investigator, who are not directly involved in data collection or data analysis
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double blinded randomized clinical trial with a test and placebo group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, dr. odont., PhD, DDS

Study Record Dates

First Submitted

August 22, 2022

First Posted

August 29, 2022

Study Start

September 1, 2022

Primary Completion

July 1, 2023

Study Completion

December 31, 2023

Last Updated

November 2, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

All microbial data will be shared, as these will be uploaded to a publically accessible database. In accordance with GDPR, immunological and clinical data will only be shared as mean (range) values.

Locations